Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.78 USD | -4.26% |
|
-17.79% | -34.00% |
06-28 | Needham Trims Price Target on Rocket Pharmaceuticals to $52 From $53, Maintains Buy Rating | MT |
06-28 | Rocket Pharmaceuticals Says FDA Seeks More Information on Kresladi | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.00% | 1.88B | |
+16.44% | 122B | |
+18.94% | 114B | |
+19.62% | 25.71B | |
-25.37% | 19.02B | |
-20.21% | 15.83B | |
-20.20% | 15.32B | |
-47.37% | 14.88B | |
+59.91% | 14.82B | |
+4.35% | 14.1B |
- Stock Market
- Equities
- RCKT Stock
- News Rocket Pharmaceuticals, Inc.
- Rocket Pharmaceuticals Insider Sold Shares Worth $315,744, According to a Recent SEC Filing